Form 8-K - Current report:
SEC Accession No. 0001213900-22-039422
Filing Date
2022-07-14
Accepted
2022-07-14 17:00:13
Documents
12
Period of Report
2022-07-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea162775-8k_abvcbio.htm   iXBRL 8-K 25464
  Complete submission text file 0001213900-22-039422.txt   196780

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE abvc-20220714.xsd EX-101.SCH 3039
3 XBRL LABEL FILE abvc-20220714_lab.xml EX-101.LAB 34476
4 XBRL PRESENTATION FILE abvc-20220714_pre.xml EX-101.PRE 22599
6 EXTRACTED XBRL INSTANCE DOCUMENT ea162775-8k_abvcbio_htm.xml XML 3496
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40700 | Film No.: 221083509
SIC: 2834 Pharmaceutical Preparations